Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature

NCT05288127 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

HRD 100 Gene Expression High
Triple Negative Breast Cancer

Interventions

DRUG: Talazoparib

Sponsor

University of Malaya

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]